![]() Chengdu Push Bio-technology Chengdu Push Bio-technology (成都普思生物科技股份有限公司) is a provider of separation and purification of natural medicines and pharmaceutical research services. | ![]() Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. | ![]() Fortrea Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO). | ![]() Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. | ![]() Hutchison China Meditech Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products. | |
Founding Date | Founding Date 2005 | Founding Date 1849 | Founding Date 2023 | Founding Date 1996 | Founding Date 2000 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Cheng Du Shi, CN HQ | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | Locations Durham, US HQ Buenos Aires, AR Melbourne, AU Sydney, AU Zaventem, BE Sao Paulo, BR Sofia, BG see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Shanghai, CN HQ Beijing, CN Jiangsu, CN Shanghai, CN Shanghai, CN Hong Kong, HK Hong Kong, HK see more |
Employees | Employees N/A | Employees 81,0008% decrease | Employees 19,000 | Employees 75,883 | Employees 1,811 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 163.9 b | Valuation ($) 1.6 b | Valuation ($) N/A | Valuation ($) 3.6 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $62.6b (FY, 2025) | Revenue (est.) $2.7b (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $548.5m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $16.1b (FY, 2025) | Cost of goods N/A | Cost of goods $8.4b (FY, 2025) | Cost of goods $324.4m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $46.5b (FY, 2025) | Gross profit N/A | Gross profit $49.8b (FY, 2025) | Gross profit $224.2m (FY, 2025) |
Net income | Net income N/A | Net income $7.8b (FY, 2025) | Net income ($986.2m) (FY, 2025) | Net income $14b (FY, 2025) | Net income $435.1m (FY, 2025) |
Operating ⚠ | |||||
Countries | Countries N/A | Countries 200 (FY, 2024) | Countries 90 (Jul, 2023) | Countries N/A | Countries N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products 32 (FY, 2024) | Phase III Trials Products N/A | Phase III Trials Products 44 (FY, 2022) | Phase III Trials Products N/A |
Registration Phase Products | Registration Phase Products N/A | Registration Phase Products 5 (FY, 2024) | Registration Phase Products N/A | Registration Phase Products 8 (FY, 2022) | Registration Phase Products N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 6.5m | Total funding raised $ 100m |

Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View company
Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO).
View company
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View company
Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products.
View company